We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.02B
AUM Growth
+$373M
Cap. Flow
+$61M
Cap. Flow %
1.52%
Top 10 Hldgs %
31.55%
Holding
1,022
New
18
Increased
240
Reduced
251
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 23.88%
2 Healthcare 23.21%
3 Financials 12.51%
4 Consumer Discretionary 9.74%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$215M 5.35%
1,652,126
-7,975
-0.5% -$1.14M
MSFT icon
2
Microsoft
MSFT
$2.99T
$186M 4.62%
773,708
+15,870
+2% +$3.81M
JNJ icon
3
Johnson & Johnson
JNJ
$599B
$143M 3.57%
810,363
+26,825
+3% +$4.63M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.06T
$122M 3.03%
394,179
+133,312
+51% +$39.6M
AVGO icon
5
Broadcom
AVGO
$1.8T
$111M 2.77%
1,990,250
+110,340
+6% +$5.53M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.29T
$107M 2.66%
1,205,574
-18,822
-2% -$1.8M
HD icon
7
Home Depot
HD
$332B
$101M 2.52%
320,267
+23,130
+8% +$7.05M
PFE icon
8
Pfizer
PFE
$141B
$96.4M 2.4%
1,882,150
+38,584
+2% +$1.85M
UNH icon
9
UnitedHealth
UNH
$383B
$93.4M 2.33%
176,191
+10,570
+6% +$5.6M
CVS icon
10
CVS Health
CVS
$137B
$92.4M 2.3%
991,306
+160,896
+19% +$15.5M
LHX icon
11
L3Harris
LHX
$52.3B
$91.6M 2.28%
440,127
+22,720
+5% +$5.12M
ABBV icon
12
AbbVie
ABBV
$448B
$83.1M 2.07%
514,337
+10,982
+2% +$1.68M
MCD icon
13
McDonald's
MCD
$190B
$82.7M 2.06%
313,742
+2,686
+0.9% +$709K
CDW icon
14
CDW
CDW
$16.6B
$80.3M 2%
449,813
+22,991
+5% +$4.04M
BMY icon
15
Bristol-Myers Squibb
BMY
$123B
$79.6M 1.98%
1,106,504
+107,063
+11% +$8.07M
TMO icon
16
Thermo Fisher Scientific
TMO
$196B
$78.6M 1.96%
142,804
+4,183
+3% +$2.22M
MA icon
17
Mastercard
MA
$484B
$74.7M 1.86%
214,939
+9,188
+4% +$3.02M
CVX icon
18
Chevron
CVX
$378B
$73.5M 1.83%
409,663
+61,972
+18% +$10.8M
ACN icon
19
Accenture
ACN
$88.6B
$72.7M 1.81%
272,567
+1,118
+0.4% +$309K
BSCN
20
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$66.6M 1.66%
3,173,805
+72,718
+2% +$1.52M
V icon
21
Visa
V
$686B
$66.1M 1.65%
318,242
+19,209
+6% +$3.87M
RTX icon
22
RTX Corp
RTX
$262B
$63.6M 1.58%
629,956
+28,865
+5% +$2.71M
DHR icon
23
Danaher
DHR
$142B
$59.5M 1.48%
252,692
+15,375
+6% +$3.56M
AON icon
24
Aon
AON
$77.5B
$57.1M 1.42%
190,342
+12,925
+7% +$3.78M
LRCX icon
25
Lam Research
LRCX
$384B
$55.8M 1.39%
1,327,660
+105,710
+9% +$4.42M

Similar funds

HM Payson & Co's Q4 2022 Portfolio in Review

As of Q4 2022, HM Payson & Co held 1,022 positions worth $4.02B, up 10% from $3.64B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

HM Payson & Co's Q4 2022 filing shows 18 new, 240 increased, 251 reduced and 90 closed positions. Its largest new stake was Schwab 1-5 Year Corporate Bond ETF: 130,000 shares worth $3.05M. The largest sale was Invesco BulletShares 2022 Corporate Bond ETF, an estimated $53.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q4 2022 buy was Schwab 1-5 Year Corporate Bond ETF: 130,000 shares worth $3.05M.
  • HM Payson & Co added most to Berkshire Hathaway Class B in Q4 2022, an estimated $39.6M increase.
  • HM Payson & Co's biggest Q4 2022 reduction was Broadridge, cutting an estimated $31.7M.
  • HM Payson & Co fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $53.4M.
  • HM Payson & Co's ten largest holdings make up 32% of its $4.02B portfolio in Q4 2022.
  • HM Payson & Co opened 18 new positions and closed 90 in Q4 2022.
  • HM Payson & Co's portfolio value rose 10% quarter-over-quarter to $4.02B.

Based on HM Payson & Co's 13F filing for Q4 2022, filed 6 Feb 2023.